GENETIC POLYMORPHISMS OF IL-17A IN ASSOCIATION WITH THE RISK OF PULMONARY TUBERCULOSIS IN IRAQI PATIENTS

Authors

  • Nada Yas Ameen Department of Biololgy, College of Science, University of Anbar, Iraq.
  • Mohammed Qais Abed Department of Biololgy, College of Science, University of Anbar, Iraq.
  • Nawal Mohammed Utba Department of Biololgy, College of Science, University of Baghdad, Iraq.
  • Ahmed Asmar Mankhi Department of National Center for Thoracic and Respiratory Diseases, Ministry of Public Health, Baghdad, Iraq.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i10.26008

Keywords:

Tuberculosis, Cytokine, IL-17A, Polymorphism, Association, Amplification refractory mutation system

Abstract

Objectives: Tuberculosis (TB) is an infectious disease that usually affects the lungs caused by Mycobacterium tuberculosis, TB is the second biggest killer, globally. The aim of this study was to examine the association between IL-17A rs2275913 SNP and pulmonary TB susceptibility in Iraqi population.

Methods: From January 2017 to April 2017, 80 pulmonary TB patients were selected as the case group, another 40 healthy control were enrolled as the control group. The genotype frequencies of IL-17A rs2275913 was detected using amplification refractory mutation system.

Results: The results of IL-17A serum level demonstrated that there were significant differences (p<0.05) between patients groups. The result showed that A allele have a higher frequency (55% vs. 50%) in TB patients than the control sample with OR value of 1.22 and EF value 0.1 and G have lower frequency (45% vs. 50%) in TB patients than control sample with OR value of 0.82 with PF value of 0.09, but this difference was not statistically significant (p>0.05).

Conclusion: There were no significant associations between IL-17A rs2275913 polymorphism and risk of TB in Iraqi population.

Downloads

Download data is not yet available.

Author Biography

Nada Yas Ameen, Department of Biololgy, College of Science, University of Anbar, Iraq.

Biology

References

Corral-Fernández NE, Cortes-García JD, Bruno RS, Romano-Moreno S, Medellín-Garibay SE, Magaña-Aquino M, et al. Analysis of transcription factors, microRNAs and cytokines involved in T lymphocyte differentiation in patients with tuberculosis after directly observed treatment short-course. Tuberculosis (Edinb) 2017;105:1-8.

Dheda K, Cox H, Esmail A, Wasserman S, Chang KC, Lange C, et al. Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB? Respirology 2018;23:36-45.

Aliannejad R, Bahrmand A, Abtahi H, Seifi M, Safavi E, Abdolrahimi F, et al. Accuracy of a new rapid antigen detection test for pulmonary tuberculosis. Iran J Microbiol 2016;8:238-42.

Erie H, Kaboosi H, Javid N, Shirzad-Aski H, Taziki M, Kuchaksaraee MB, et al. The high prevalence of Mycobacterium tuberculosis Beijing strain at an early age and extra-pulmonary tuberculosis cases. Iran J Microbiol 2017;9:312-7.

Sajith MA, Thomas JJ, Kothia B, Chandrakar B, Pawar A, Bargaje MD. Cost of therapy incurred for tuberculosis patients receiving directly observed therapy (DOT). Int J Pharm Pharm Sci 2015;7:141-4.

Choi R, Kim K, Kim MJ, Kim SY, Kwon OJ, Jeon K, et al. Serum inflammatory profiles in pulmonary tuberculosis and their association with treatment response. J Proteomics 2016;149:23-30.

Narooie-Nejad M. Role of cytokine’s functional single nucleotide polymorphisms in tuberculosis. Gene Cell Tissue 2017;4:e13337.

Lindenau JD, Guimarães LS, Friedrich DC, Hurtado AM, Hill KR, Salzano FM, et al. Cytokine gene polymorphisms are associated with susceptibility to tuberculosis in an Amerindian population. Int J Tuberc Lung Dis 2014;18:952-7.

Muller BL, Ramalho DM, Santos PF, Mesquita ED, Kritski AL, Oliveira MM, et al. Inflammatory and immunogenetic markers in correlation with pulmonary tuberculosis. J Bras Pneumol 2013;39:719 27.

Yang LJ, Gao W, Bai JY, Zhang XK, Han X, Sun YH, et al. Correlation between interleukin-17 gene polymorphism and gastric cancer susceptibility in Han Chinese population. Eur Rev Med Pharmacol Sci 2016;20:1271-82.

Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity 2011;34:149-62.

Das S, Khader S. Yin and yang of interleukin-17 in host immunity to infection. F1000Res 2017;6:741.

Liu S, Dakin LA, Xing L, Withka JM, Sahasrabudhe PV, Li W, et al. Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists. Sci Rep 2016;6:30859.

Miossec P. Update on interleukin-17: A role in the pathogenesis of inflammatory arthritis and implication for clinical practice. RMD Open 2017;3:e000284.

Teräsjärvi J, Hakanen A, Korppi M, Nuolivirta K, Gröndahl-Yli-Hannuksela K, Mertsola J, et al. Rapid detection of functional gene polymorphisms of TLRs and IL-17 using high resolution melting analysis. Sci Rep 2017;7:41522.

Eskandari-Nasab E, Moghadampour M, Tahmasebi A. Meta-analysis of risk association between interleukin-17A and F gene polymorphisms and inflammatory diseases. J Interferon Cytokine Res 2017;37:165-74.

Bulat-Kardum LJ, Etokebe GE, Lederer P, Balen S, Dembic Z. Genetic polymorphisms in the toll-like receptor 10, interleukin (IL)17A and IL17F genes differently affect the risk for tuberculosis in Croatian population. Scand J Immunol 2015;82:63-9.

Ocejo-Vinyals JG, de Mateo EP, Hoz MÃ, Arroyo JL, Agüero R, Ausín F, et al. The IL-17 G-152A single nucleotide polymorphism is associated with pulmonary tuberculosis in Northern Spain. Cytokine 2013;64:58-61.

Abhimanyu, Bose M, Komal, Varma-Basil M. Lack of association between IL17A and IL17F polymorphisms and related serum levels in north Indians with tuberculosis. Gene 2013;529:195-8.

Hur YG, Kang YA, Jang SH, Hong JY, Kim A, Lee SA, et al. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects. J Infect 2015;70:346-55.

Chen YC, Chin CH, Liu SF, Wu CC, Tsen CC, Wang YH, et al. Prognostic values of serum IP-10 and IL-17 in patients with pulmonary tuberculosis. Dis Markers 2011;31:101-10.

Liang YP, Chen Y, Xiao TY, Xia Q, Liu HC, Zhao XQ, et al. Applied multiplex allele specific PCR to detect second-line drug resistance among multidrug-resistant tuberculosis in china. Tuberculosis (Edinb) 2017;107:1-4.

Shaji J, Shaikh, M. Drug-resistant tuberculosis: Recent approach in polymer based nanomedicine. Int J Pharm Pharm Sci 2016:8:1-6.

Butov DO, Kuzhko MM, Makeeva NI, Butova TS, Stepanenko HL, Dudnyk AB, et al. Association of interleukins genes polymorphisms with multi-drug resistant tuberculosis in Ukrainian population. Pneumonol Alergol Pol 2016;84:168-73.

Basile JI, Kviatcovsky D, Romero MM, Balboa L, Monteserin J, Ritacco V, et al. Mycobacterium tuberculosis multi-drug-resistant strain M induces IL-17+ IFNγ- CD4+ T cell expansion through an IL-23 and TGF-β-dependent mechanism in patients with MDR-TB tuberculosis. Clin Exp Immunol 2017;187:160 73.

Białecka M, Ostasz R, Kurzawski M, Klimowicz A, Fabiańczyk H, Bojko P, et al. IL17A and IL17F gene polymorphism association with psoriasis risk and response to treatment in a polish population. Dermatology 2016;232:592-6.

Rolandelli A, Hernández Del Pino RE, Pellegrini JM, Tateosian NL, Amiano NO, de la Barrera S, et al. The IL-17A rs2275913 single nucleotide polymorphism is associated with protection to tuberculosis but related to higher disease severity in Argentina. Sci Rep 2017;7:40666.

Du J, Han J, Li X, Zhang Y, Li H, Yang S, et al. StIL-17 gene polymorphisms in the development of pulmonary tuberculosis. Int J Clin Exp Pathol 2015;8:3225-9.

Shi GC, Zhang LG. Influence of interleukin-17 gene polymorphisms on the development of pulmonary tuberculosis. Genet Mol Res 2015;14:8526-31.

Wang Y, Xu L, Zhang L, He Y, Yang C, Huang A. Construction the recombinant BCG targeting delivering IPRI into macrophages: A new strategy of vaccine against tuberculosis. Afr J Microbiol Res 2013;7:533-40.

Mansouri F, Heydarzadeh R, Yousefi S. The association of interferon-gamma, interleukin-4 and interleukin-17 single-nucleotide polymorphisms with susceptibility to tuberculosis. APMIS 2018;126:227-33.

Milano M, Moraes MO, Rodenbusch R, Carvalho CX, Delcroix M, Mousquer G, et al. Single nucleotide polymorphisms in IL17A and IL6 are associated with decreased risk for pulmonary tuberculosis in southern Brazilian population. PLoS One 2016;11:e0147814.

Zhang J, Zheng L, Zhu D, An H, Yang Y, Liang Y, et al. Polymorphisms in the interleukin 18 receptor 1 gene and tuberculosis susceptibility among Chinese. PLoS One 2014;9:e110734.

Published

07-10-2018

How to Cite

Ameen, N. Y., M. Q. Abed, N. M. Utba, and A. A. Mankhi. “GENETIC POLYMORPHISMS OF IL-17A IN ASSOCIATION WITH THE RISK OF PULMONARY TUBERCULOSIS IN IRAQI PATIENTS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 10, Oct. 2018, pp. 428-32, doi:10.22159/ajpcr.2018.v11i10.26008.

Issue

Section

Original Article(s)